Study of interaction of nifedipine with haloperidol on conditioned avoidance response and catalepsy in rats

Nitibhushansingh R. Chandel, Anant G. Phadke, Chhaya A. Goyal


Background: To study the interaction of calcium channel blocker (Nifedipine) with Antipsychotic drug (Haloperidol) on Conditioned avoidance Response and catalepsy in Rats.

Methods: Every group consisted of 10 healthy albino rats of either sex. Different groups received Nifedipine (5, 10 & 20 mg/kg, i.p.), Haloperidol (ED50 -0.2mg/kg for CAR & 0.4mg/kg for catalepsy) alone and combined doses of both drugs. The Antipsychotic effect of drugs was measured by Conditioned avoidance response (CAR) using Cook’s Pole climbing apparatus and Adverse drug effect (Extra pyramidal syndrome) was measured by Catalepsy.

Results: 5 mg/kg i.p. of Nifedipine inhibited CAR in 50 % of Rats (compared to control, p<0.001). 10mg/kg i.p. of Nifedipine inhibited CAR in 60% of Rats (p<0.001) & 20 mg/kg i.p. inhibited CAR in 70% of Rats (p<0.001). When Nifedipine (5 mg/kg i.p) was combined with Haloperidol ED50-0.2mg/kg  the CAR was inhibited in 70% of the rats (p<0.01) and after combining Nifedipine (10mg/kg) with Haloperidol ED50-0.2mg/kg the CAR was inhibited in 80% Rats (p<0.001). Nifedipine at the dose of 5 mg/kg and 10 mg/kg (i.p.) did not induce catalepsy in the rats at any testing time interval.  At 20 mg/kg i.p., it produced catalepsy in 2 rats at half hour and in 4 rats at 1 hour and 2 hour testing interval each (p<0.01). In the dose of 5, 10 and 20 mg/kg, pretreatment with Nifedipine significantly increased Haloperidol induced cataleptic scores at all testing intervals (p<0.05).

Conclusions: Nifedipine blocked CAR. Its higher doses induced catalepsy and it is synergistic with haloperidol in blockade of CAR and catalepsy.


Nifedipine, Haloperidol, Conditioned avoidance response (CAR), Catalepsy

Full Text:



Perez-Costas E, Melendez-Ferro M, Roberts RC. Basal ganglia pathology in Schizophrenia: Dopamine connections and Anomalies. J Neurochem 2010; 113:287-302.

Delay J, Deniker P, Harl JM. Therapeutic use in psychiatry of phenothiazine of central elective action0 (4560RP). Ann Med Psychol (Paris) 1952;110:112-7.

Carlsson A, Lindqvist M. Effect of Chlorpromazine or Haloperidol on formation of 3methoxytyramine and Normetanephrine in Mouse Brain. Acta Pharmacol Toxicol (Copenh). 1963;20:140-4.

Cresse I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and Pharmacological potencies of antischizophrenic drugs. Science 1976;192:481-3.

Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptics/dopamine receptors. Nature 1976;261:717-9.

Seeman P, Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc Natl Acad Sci U S A 2000;97:7673-5.

Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988;1:179-86.

Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptulization. Am J Psychiatry 1991;148:1474-86.

Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-The final common Pathway. Schizophr Bull 2009;35:549-62.

Patel JC, Witkovsky P, Avshalumov MV, Rice ME. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J Neurosci 2009;29:6568-79.

Olivera BM, Miljanich GP, Ramachandran J, Adams ME. Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem 1994;63:823-67.

Herdon H, Nahorski SR. Investigations of the roles of dihydropyridine and omega-conotoxin sensitive calcium channels in mediating depolarization evoked dopamine release from striatal slices. Naunyn schmiedebergs Arch Pharmacol 1989;340:36-40.

Blake BL, Muehlmann AM, Egami K, Breese GR, Devine DP, Jinnah HA. Nifedipine suppresses self-injurious behaviors in animals. Dev Neurosci 2007;29:241-50.

Khanzode SD, Mahakalkar SM, Belorkar NR, Kharkar VT, Manekar MS. Effect of Pretreatment of some calcium channel blockers on catalepsy and stereotypic behavior in rats. Indian J Physiol Pharmacol 1996;40:159-62.

Kozlovskiĭ VL, Prakh'e IV, Kenunen OG. The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats. Eksp Klin Farmakol 1996;59:12-5.

Alessi NE, Walden M, Hsieh PS. Nifedipine-haloperidol combination in the treatment of Gilles de la Tourette’s syndrome: a case study. J Clin Psychiatry 1989;50:103-4.

Marinelli M, Rudick CN, HuXT, White FJ. Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets 2006;5:79-97.

Suddath RL, Straw GM, Freed WJ, Bigelow LB, Kirch DG, Wyatt RJ. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. Pharmacol Biochem Behav 1991;39:743-5.

Duncan E, Adler L, Angrist B, Rotrosen J. Nifedipine in treatment of Tardive dyskinesia. J Clin Psychopharmacol 1990;10:414-6.

Wadenburg ML. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 1996;20:325-39.

Wadenburg ML, Hicks PB. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biobehav Rev 1999;23:851-62.

Cook L, Weidley E. Behavioral effects of some psychopharmacological agents. Ann N Y Acad Sci 1957; 66:740-52.

Costall B, Naylor RJ. Mesolimbic involvement with behavioral effects indicating antipsychotic activity. Eur J Pharmacol 1974;27:46-58.

Wadenberg ML, Soliman A, VanderSpek SC, Kapur S. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 2001;25:633-41.

Biala G. Haloperidol induced catalepsy is influenced by calcium channel antagonists Acta Pol Pharm 2000;57:233-7.